NovaBay Pharmaceuticals Inc. (NBY) Fell -5.9% or -0.18 To Price $2.87 On Tuesday


NovaBay Pharmaceuticals Inc. (NBY) fell -5.9% or -0.18 to $2.87. It is near 11904 shares traded, which is 248.16% compare to the average total volume 4797. The market cap of NBY is $49.05 million. The year to date change is -25.61%. The 52 week price range is from $2.25 to $5.0. Price of NBY have changed 2.79% during last week. It have changed -7.85% over last month, -11.59% over last 3 months, -31.46% over last 6 months and 15.09% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBY is 3.25. It is 13.24% above current price. The 200-day Moving Averages for NBY is 3.86. It is 34.49% above current price. The 52-week High is 5.0. It is 74.22% from the current price. The 52-week Low is 2.25. It is -21.60% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBY is 43.74 on 2018-04-30. Short % to float is 0.91%. There are some statistics of NBY. It is has market cap $49.05 million. The share outstanding is 17.09 million. The average volume is 4797. The revenue is 8.21M. The gross profit is 6.99M. The percent of top 15 Institution holding is 0.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBY is -152.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBY is -58.15%.


Tags:

Share this post